title: [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
abstract: 76 patients with severe venous insufficiency (CVI) entered the study. All the patients received 500 mg of Detralex twice daily for 2 months. The drug was well tolerated and relieved CVI symptoms in the majority of cases.
authors.forename: E G
authors.initials: EG
authors.lastname: Iablokov
authors.forename: V Iu
authors.initials: VIu
authors.lastname: Bogachev
authors.forename: A I
authors.initials: AI
authors.lastname: Domoradskaia
mesh_terms: D002908:Chronic Disease; D004145:Diosmin / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005419:Flavonoids / Q000009:adverse effects / Q000627:therapeutic use*; D006569:Hesperidin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D013607:Tablets; D013997:Time Factors; D014689:Venous Insufficiency / Q000188:drug therapy*
chemical_list: D004338:Drug Combinations; D005419:Flavonoids; D013607:Tablets; C080675:S 5682; D004145:Diosmin; D006569:Hesperidin